SKAN expands global reach, reports double-digit growth in 2024

Published 25/03/2025, 08:24
© Reuters.

Investing.com -- SKAN Group (SIX:SKAN)p on Tuesday reported record results in 2024, with a 21.8% surge in order intake to CHF 359.5 million and a 12.9% increase in net sales to CHF 361.3 million. 

The Swiss company’s EBITDA rose by 13.6% to CHF 57 million, maintaining a margin of 15.8%. 

According to SKAN, the demand was driven by "the ongoing trend towards injectable drugs, and thus towards our process solutions for the aseptic filling of biopharmaceutical active ingredients, ensuring high demand among our customers."

The Equipment & Solutions segment remained SKAN’s primary revenue driver, contributing 75% of total sales. 

The segment recorded an EBITDA increase of 12.9% to CHF 30.3 million, with a margin of 11.2%. Meanwhile, the Services & Consumables segment saw an order intake increase of 27.6%, pushing net sales to CHF 90.4 million. 

This segment’s EBITDA grew by 14.4% to CHF 26.6 million, with a strong margin of 29.5%.

In Asia, order intake more than doubled to CHF 48.1 million, bringing its share to 13.4% from 6.4%. 

Europe remained the largest market, with order intake reaching CHF 207 million, an increase of 17.6%. The Americas posted a modest increase to CHF 97.9 million, up 3.2%.

SKAN’s net profit surged by 46.2% to CHF 40.8 million, reflecting strong operational performance. 

The company’s equity increased by 14.9% to CHF 202.6 million, while operating cash flow saw a jump from CHF 8.7 million in 2023 to CHF 46.7 million in 2024, highlighting improved cash generation and financial stability.

Investments for the year totaled CHF 53.8 million, with a focus on infrastructure expansion in Switzerland, Germany, and Belgium, as well as an increased stake in Aseptic Technologies S.A. 

The establishment of SKAN do Brasil Ltda. marked an important milestone in its international growth strategy.

SKAN expects mid-teens percentage sales growth in 2025, with an EBITDA margin target of 14-16%. 

The company acknowledged potential short-term project execution delays but expressed confidence in its ability to recover, stating, "From today’s perspective, the Board of Directors and Management expect a subdued sales development in the first half of 2025. However, we assume that the resulting shortfall in sales and earnings can be largely compensated for in the second half of the year."

The Board of Directors has proposed a dividend of CHF 0.40 per share for 2024, reflecting a 14.3% increase, while earnings per share climbed 47.5% to CHF 1.73.

SKAN’s workforce grew by 83 employees to 1,471, representing a 6% increase, with total headcount, including temporary staff, reaching 1,654.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.